---
title: "NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026"
ocid: "ocds-h6vhtk-051c98"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-051c98"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-051c98.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-051c98.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "NHS ENGLAND"
published: "2026-06-23"
---

# NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026

Buyer: NHS ENGLAND  
Current stage: Award  
OCID: ocds-h6vhtk-051c98

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-051c98)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-051c98.json)

## Summary

The public procurement contracting process led by NHS England relates to the award of a framework agreement for NHS Branded Medicines, specifically Tranche A for the North of England and Midlands & East, and Natalizumab for London and the South of England. The procurement, identified under OCID ocds-h6vhtk-051c98, involves two lots with contracts pegged to commence on 1st September 2026. Lot 1 covers the period until 31st August 2028 with a possible extension of up to 24 months, while Lot 2 runs until 31st August 2027 and can be extended for another 12 months. The industry category is 'Pharmaceutical products' and the procurement was conducted using an open procedure, with a total value of awards amounting to over £1 billion, highlighting its significance. Key dates include the standstill period ending on 2nd July 2026 and contract signatures anticipated by 6th July 2026.

This procurement presents significant opportunities for businesses within the pharmaceutical sector, particularly large companies capable of supplying branded medicines on a substantial scale. With bidders like Aventis Pharma (Sanofi), Accord-UK Ltd, and Biogen Idec involved, there's a strong emphasis on extensive production and distribution capabilities. Companies suited to compete in this tender include those already operating in Europe and who can demonstrate scalability and strong logistical strategies to meet NHS England's needs across the multiple geographical regions specified by the framework agreements. The framework’s potential extensions further enhance its appeal to businesses aiming for long-term growth through sustained partnerships with a major public authority.

## Notice

NHS Branded Framework Agreement - Lot 1 - Tranche A for the North of England and Midlands & East. Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority's discretion for a further 24 months. Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.

### Lot Information

CM/PHR/25/5730/01 - Tranche B for NOFE and MAE

Lot 1 - Tranche A for the North of England and Midlands & East. Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority's discretion for a further 24 months.

Options: CM/PHR/25/5730/01 - Lot 1 - Tranche A for North of England and Midlands & East 01/09/2026 - 31/08/2028 (24 Months) with an option or option(s) to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Renewal: With an option or option(s) to extend for a further 24 months.

CM/PHR/25/5730/02 - Natalizumab for London & SOFE

Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement : 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.

Options: CM/PHR/25/5730/01 - Lot 1 - Tranche A for North of England and Midlands & East 01/09/2026 - 31/08/2028 (24 Months) with an option or option(s) to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Renewal: With an option or option(s) to extend for a further 12 months.

### Planning Information

NHS England is advising suppliers of an upcoming tender for the NHS Branded Framework Agreement – Tranche A for the North of England and Midlands & East. 
Period of Framework Agreement (Lot 1): 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months.
There will be a separate Lot to provide framework agreement coverage to the London and South of England regions for Natalizumab. The period of Framework Agreement (Lot 2): 1st September 2026 to 31st August 2027 with the option or option(s) to extend for a further 12 months.
Eight category areas are covered in Tranche A: Erythropoietin Stimulating Agents, Granulocyte-Colony Stimulating Factor (GCSF), Insulin Analogues, MS Drugs, Parenteral Iron, Severe Asthma, Severe Asthma/Interleukin Inhibitor and Teriparatide.
The purpose of this notice is to inform existing and potential new suppliers that if NHS England believe that it would be beneficial a virtual 1:1 preliminary market meeting can be arranged.  Please contact ian.birch1@nhs.net to register your interest. There will also be a 14 day window for queries to be raised via Atamis after all sessions have concluded.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/058925-2026 |
| Notice type | UK6 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | SME |
| Awardee scale | Large, SME |
| All stages | Planning, Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 23 Jun 2026 |
| Submission deadline | 17 Apr 2026 |
| Future notice date | 17 Mar 2026 |
| Award date | 14 Jun 2026 |
| Contract period | 31 Aug 2026 - 31 Aug 2027 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £877,670,570 |
| Lots value | £877,670,570 |
| Awards value | £201,659,945 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Pending |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Locality | LONDON |
| Post town | South East London |
| Postcode | SE1 8UG |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI4 Inner London - East |
| ITL 3 | TLI45 Lambeth |
| Local authority | Lambeth |
| Electoral ward | Waterloo & South Bank |
| Westminster constituency | Vauxhall and Camberwell Green |
| Delivery location | TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLI London, TLJ South East (England), TLK South West (England) |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 25 |
| Supplier names | ACCORD-UK; AMGEN; AVENTIS PHARMA LIMITED T-A SANOFI; BAYER; BIOGEN IDEC; CHUGAI PHARMA; CIPLA (EU; CST PHARMA; ELI LILLY; GEDEON RICHTER (UK; GLAXOSMITHKLINE; LABORATORIES JUVISE PHARMACEUTICALS; MERCK SERONO; MILPHARM; NAPP PHARMACEUTICALS; NOVO NORDISK; ORIFARM; PFIZER; PHARMACOSMOS; ROCHE PRODUCTS; SANDOZ; TEVA; THORNTON & ROSS; VIATRIS UK HEALTHCARE; VIFOR PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 23 Jun 2026 at 11:33 - Award - UK6 - Contract Award Notice - https://www.find-tender.service.gov.uk/Notice/058925-2026
- 17 Mar 2026 at 12:14 - Tender - UK4 - Tender Notice - https://www.find-tender.service.gov.uk/Notice/023990-2026
- 13 Mar 2026 at 15:08 - PlanningUpdate - UK2 - Preliminary Market Engagement Notice - https://www.find-tender.service.gov.uk/Notice/023102-2026
- 13 Jan 2026 at 09:57 - Planning - UK2 - Preliminary Market Engagement Notice - https://www.find-tender.service.gov.uk/Notice/002508-2026
- 3 Jun 2025 at 11:41 - PlanningUpdate - UK1 - Pipeline Notice - https://www.find-tender.service.gov.uk/Notice/029473-2025
- 22 May 2025 at 08:34 - Planning - UK1 - Pipeline Notice - https://www.find-tender.service.gov.uk/Notice/024471-2025

## Documents

- https://www.find-tender.service.gov.uk/Notice/058925-2026
  23rd June 2026 - Contract award notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/023990-2026
  17th March 2026 - Tender notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/023102-2026
  13th March 2026 - Preliminary market engagement notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/002508-2026
  13th January 2026 - Preliminary market engagement notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/029473-2025
  3rd June 2025 - Pipeline notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/024471-2025
  22nd May 2025 - Pipeline notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-13420
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-13421
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-13422
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-13423
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-13424
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-13425
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-13426
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-13427
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-13428
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-13429
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-13430
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-13431
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-13432
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-13433
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-13434

## Notice URLs

- https://health-family.force.com/s/Welcome
- https://www.england.nhs.uk/
- https://www.legislation.gov.uk/ukpga/2023/54/contents

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-051c98. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-051c98.json.